bibliographic resource 2213766 [br/2213766]
https://w3id.org/oc/corpus/br/2213766

is a
title
  • Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
publication date
  • 2010-01-01
contributor
format
identifier
part of